Connection

Marco Metra to Follow-Up Studies

Back to Details
This is a "connection" page, showing publications Marco Metra has written about Follow-Up Studies.
Marco Metra
Connection Strength
0.383
Follow-Up Studies
  1. Pulmonary embolism in patients with COVID-19: characteristics and outcomes in the Cardio-COVID Italy multicenter study. Clin Res Cardiol. 2021 Jul; 110(7):1020-1028.
    View in: PubMed
    Score: 0.057
  2. The role of type 2 diabetes mellitus on hypertensive-related aortic stiffness. Echocardiography. 2018 06; 35(6):798-803.
    View in: PubMed
    Score: 0.047
  3. Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 study. Eur J Heart Fail. 2017 06; 19(6):800-809.
    View in: PubMed
    Score: 0.045
  4. Coronavirus disease 2019 (COVID-19) in the heart transplant population: a single-centre experience. Eur J Cardiothorac Surg. 2020 11 01; 58(5):899-906.
    View in: PubMed
    Score: 0.014
  5. COVID-19 in Heart Transplant Recipients: A Multicenter Analysis of the Northern Italian Outbreak. JACC Heart Fail. 2021 01; 9(1):52-61.
    View in: PubMed
    Score: 0.014
  6. The clinical significance of interleukin-6 in heart failure: results from the BIOSTAT-CHF study. Eur J Heart Fail. 2019 08; 21(8):965-973.
    View in: PubMed
    Score: 0.013
  7. Heart failure prognosis over time: how the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 years. Eur J Heart Fail. 2019 02; 21(2):208-217.
    View in: PubMed
    Score: 0.013
  8. Left ventricular reverse remodelling predicts long-term outcomes in patients with functional mitral regurgitation undergoing MitraClip therapy: results from a multicentre registry. Eur J Heart Fail. 2019 02; 21(2):196-204.
    View in: PubMed
    Score: 0.013
  9. Dose-dependent efficacy of ß-blocker in patients with chronic heart failure and atrial fibrillation. Int J Cardiol. 2018 Dec 15; 273:141-146.
    View in: PubMed
    Score: 0.012
  10. Circulating Cardiac Troponin I Levels Measured by a Novel Highly Sensitive Assay in Acute Decompensated Heart Failure: Insights From the ASCEND-HF Trial. J Card Fail. 2018 Aug; 24(8):512-519.
    View in: PubMed
    Score: 0.012
  11. Factors influencing early referral, early diagnosis and management in patients with diffuse cutaneous systemic sclerosis. Rheumatology (Oxford). 2018 05 01; 57(5):813-817.
    View in: PubMed
    Score: 0.012
  12. Fibroblast growth factor 23 is related to profiles indicating volume overload, poor therapy optimization and prognosis in patients with new-onset and worsening heart failure. Int J Cardiol. 2018 02 15; 253:84-90.
    View in: PubMed
    Score: 0.012
  13. Potassium and the use of renin-angiotensin-aldosterone system inhibitors in heart failure with reduced ejection fraction: data from BIOSTAT-CHF. Eur J Heart Fail. 2018 05; 20(5):923-930.
    View in: PubMed
    Score: 0.012
  14. Aetiology, timing and clinical predictors of early vs. late readmission following index hospitalization for acute heart failure: insights from ASCEND-HF. Eur J Heart Fail. 2018 02; 20(2):304-314.
    View in: PubMed
    Score: 0.012
  15. Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: a long-term comparison. Eur J Heart Fail. 2018 04; 20(4):700-710.
    View in: PubMed
    Score: 0.011
  16. Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure: From the ASCEND-HF Trial. J Am Coll Cardiol. 2017 Jun 27; 69(25):3029-3039.
    View in: PubMed
    Score: 0.011
  17. Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo-controlled trial. Eur J Heart Fail. 2017 11; 19(11):1495-1503.
    View in: PubMed
    Score: 0.011
  18. Measurement of troponin and natriuretic peptides shortly after admission in patients with heart failure-does it add useful prognostic information? An analysis of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Studies (VERITAS). Eur J Heart Fail. 2017 06; 19(6):739-747.
    View in: PubMed
    Score: 0.011
  19. Prognostic role of ß-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database. Eur J Heart Fail. 2017 07; 19(7):904-914.
    View in: PubMed
    Score: 0.011
  20. Percutaneous edge-to-edge mitral valve repair for the treatment of acute mitral regurgitation complicating myocardial infarction: A single centre experience. Int J Cardiol. 2017 May 01; 234:53-57.
    View in: PubMed
    Score: 0.011
  21. A multimarker multi-time point-based risk stratification strategy in acute heart failure: results from the RELAX-AHF trial. Eur J Heart Fail. 2017 08; 19(8):1001-1010.
    View in: PubMed
    Score: 0.011
  22. Hemodynamic Predictors of Heart Failure Morbidity and Mortality: Fluid or Flow? J Card Fail. 2016 Mar; 22(3):182-9.
    View in: PubMed
    Score: 0.010
  23. Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: a multiparametric approach to heart failure prognosis. Int J Cardiol. 2013 Sep 10; 167(6):2710-8.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.